Works by Monkhorst, Kim


Results: 29
    1
    2

    Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24537-3
    By:
    • Prekovic, Stefan;
    • Schuurman, Karianne;
    • Mayayo-Peralta, Isabel;
    • Manjón, Anna G.;
    • Buijs, Mark;
    • Yavuz, Selçuk;
    • Wellenstein, Max D.;
    • Barrera, Alejandro;
    • Monkhorst, Kim;
    • Huber, Anne;
    • Morris, Ben;
    • Lieftink, Cor;
    • Chalkiadakis, Theofilos;
    • Alkan, Ferhat;
    • Silva, Joana;
    • Győrffy, Balázs;
    • Hoekman, Liesbeth;
    • van den Broek, Bram;
    • Teunissen, Hans;
    • Debets, Donna O.
    Publication type:
    Article
    3
    4

    Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).

    Published in:
    BMC Medical Genomics, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s12920-020-00814-w
    By:
    • Samsom, Kris G.;
    • Bosch, Linda J. W.;
    • Schipper, Luuk J.;
    • Roepman, Paul;
    • de Bruijn, Ewart;
    • Hoes, Louisa R.;
    • Riethorst, Immy;
    • Schoenmaker, Lieke;
    • van der Kolk, Lizet E.;
    • Retèl, Valesca P.;
    • Frederix, Geert W. J.;
    • Buffart, Tineke E.;
    • van der Hoeven, Jacobus J. M.;
    • Voest, Emile E.;
    • Cuppen, Edwin;
    • Monkhorst, Kim;
    • Meijer, Gerrit A.
    Publication type:
    Article
    5
    6
    7
    8
    9

    Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.

    Published in:
    Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01521
    By:
    • van den Broek, Daan;
    • Hiltermann, T. Jeroen N.;
    • Biesma, Bonne;
    • Dinjens, Winand N. M.;
    • 't Hart, Nils A.;
    • Hinrichs, John W. J.;
    • Leers, Mathie P. G.;
    • Monkhorst, Kim;
    • van Oosterhout, Matthijs;
    • Scharnhorst, Volkher;
    • Schuuring, Ed;
    • Speel, Ernst-Jan M.;
    • van den Heuvel, Michel M.;
    • van Schaik, Ron H. N.;
    • von der Thüsen, Jan;
    • Willems, Stefan M.;
    • de Visser, Leonie;
    • Ligtenberg, Marjolijn J. L.
    Publication type:
    Article
    10

    Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.

    Published in:
    Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2019.01521
    By:
    • van den Broek, Daan;
    • Hiltermann, T. Jeroen N.;
    • Biesma, Bonne;
    • Dinjens, Winand N. M.;
    • 't Hart, Nils A.;
    • Hinrichs, John W. J.;
    • Leers, Mathie P. G.;
    • Monkhorst, Kim;
    • van Oosterhout, Matthijs;
    • Scharnhorst, Volkher;
    • Schuuring, Ed;
    • Speel, Ernst-Jan M.;
    • van den Heuvel, Michel M.;
    • van Schaik, Ron H. N.;
    • von der Thüsen, Jan;
    • Willems, Stefan M.;
    • de Visser, Leonie;
    • Ligtenberg, Marjolijn J. L.
    Publication type:
    Article
    11
    12

    Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients.

    Published in:
    Cancers, 2022, v. 14, n. 2, p. 436, doi. 10.3390/cancers14020436
    By:
    • Schipper, Luuk J.;
    • Monkhorst, Kim;
    • Samsom, Kris G.;
    • Bosch, Linda J.W.;
    • Snaebjornsson, Petur;
    • van Boven, Hester;
    • Roepman, Paul;
    • van der Kolk, Lizet E.;
    • van Houdt, Winan J.;
    • van der Graaf, Winette T.A.;
    • Meijer, Gerrit A.;
    • Voest, Emile E.
    Publication type:
    Article
    13
    14
    15
    16

    Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.

    Published in:
    Oncologist, 2021, v. 26, n. 8, p. e1347, doi. 10.1002/onco.13580
    By:
    • Koopman, Bart;
    • Groen, Harry J.M.;
    • Ligtenberg, Marjolijn J.L.;
    • Grünberg, Katrien;
    • Monkhorst, Kim;
    • de Langen, Adrianus J.;
    • Boelens, Mirjam C.;
    • Paats, Marthe S.;
    • von der Thüsen, Jan H.;
    • Dinjens, Winand N.M.;
    • Solleveld, Nienke;
    • van Wezel, Tom;
    • Gelderblom, Hans;
    • Hendriks, Lizza E.;
    • Speel, Ernst‐Jan M.;
    • Theunissen, Tom E.;
    • Kroeze, Leonie I.;
    • Mehra, Niven;
    • Piet, Berber;
    • van der Wekken, Anthonie J.
    Publication type:
    Article
    17
    18

    Blastic plasmacytoid dendritic cell neoplasm.

    Published in:
    British Journal of Haematology, 2014, v. 164, n. 6, p. 757, doi. 10.1111/bjh.12666
    By:
    • Roodbergen, Sofie L.;
    • Hofland, Johannes;
    • Lam, King H.;
    • Dikrama, Petra K.;
    • Broyl, Annemiek;
    • Monkhorst, Kim
    Publication type:
    Article
    19
    20

    Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study.

    Published in:
    PLoS Medicine, 2025, v. 22, n. 4, p. 1, doi. 10.1371/journal.pmed.1004574
    By:
    • Schuurbiers, Milou M. F.;
    • Smith, Christopher G.;
    • Hartemink, Koen J.;
    • Rintoul, Robert C.;
    • Gale, Davina;
    • Monkhorst, Kim;
    • Mandos, Bas L. R.;
    • Paterson, Anna L.;
    • van den Broek, Dan;
    • Rosenfeld, Nitzan;
    • van den Heuvel, Michel M.
    Publication type:
    Article
    21

    Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis.

    Published in:
    Interactive Cardiovascular & Thoracic Surgery, 2022, v. 34, n. 4, p. 566, doi. 10.1093/icvts/ivab291
    By:
    • Joosten, Pieter J M;
    • Dickhoff, Chris;
    • van der Noort, Vincent;
    • Smeekens, Maarten;
    • Numan, Rachel C;
    • Klomp, Houke M;
    • Diessen, Judi N A van;
    • Belderbos, Jose S A;
    • Smit, Egbert F;
    • Monkhorst, Kim;
    • Oosterhuis, Jan W A;
    • Heuvel, Michel M van den;
    • Dahele, Max;
    • Hartemink, Koen J
    Publication type:
    Article
    22

    Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.

    Published in:
    PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216864
    By:
    • Theelen, Willemijn S. M. E.;
    • Kuilman, Thomas;
    • Schulze, Katja;
    • Zou, Wei;
    • Krijgsman, Oscar;
    • Peters, Dennis D. G. C.;
    • Cornelissen, Sten;
    • Monkhorst, Kim;
    • Sarma, Pranamee;
    • Sumiyoshi, Teiko;
    • Amler, Lukas C.;
    • Willems, Stefan M.;
    • Blaauwgeers, Johannes L. G.;
    • van Noesel, Carel J. M.;
    • Peeper, Daniel S.;
    • van den Heuvel, Michel M.;
    • Kowanetz, Marcin
    Publication type:
    Article
    23

    Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.

    Published in:
    2020
    By:
    • van Geel, Robin M. J. M.;
    • van Brummelen, Emilie M. J.;
    • Eskens, Ferry A. L. M.;
    • Huijberts, Sanne C. F. A.;
    • de Vos, Filip Y. F. L.;
    • Lolkema, Martijn P. J. K.;
    • Devriese, Lot A.;
    • Opdam, Frans L.;
    • Marchetti, Serena;
    • Steeghs, Neeltje;
    • Monkhorst, Kim;
    • Thijssen, Bas;
    • Rosing, Hilde;
    • Huitema, Alwin D. R.;
    • Beijnen, Jos H.;
    • Bernards, René;
    • Schellens, Jan H. M.
    Publication type:
    journal article
    24
    25
    26

    Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2316, doi. 10.1093/neuonc/noae138
    By:
    • Wel, J W Tijmen van der;
    • Boelens, Mirjam C;
    • Jebbink, Merel;
    • Smulders, Sietske A;
    • Maas, Klaartje W;
    • Luitse, Merel J A;
    • Compter, Annette;
    • Boltjes, Robin P B;
    • Sol, Nik;
    • Monkhorst, Kim;
    • van den Broek, Daan;
    • Smit, Egbert F;
    • Langen, Adrianus J de;
    • Brandsma, Dieta
    Publication type:
    Article
    27

    Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer.

    Published in:
    Molecular Oncology, 2024, v. 18, n. 6, p. 1417, doi. 10.1002/1878-0261.13555
    By:
    • Böttger, Franziska;
    • Radonic, Teodora;
    • Bahce, Idris;
    • Monkhorst, Kim;
    • Piersma, Sander R.;
    • Pham, Thang V.;
    • Dingemans, Anne‐Marie C.;
    • Hillen, Lisa M.;
    • Santarpia, Mariacarmela;
    • Giovannetti, Elisa;
    • Smit, Egbert F.;
    • Burgers, Sjaak A.;
    • Jimenez, Connie R.
    Publication type:
    Article
    28

    Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patients.

    Published in:
    Molecular Oncology, 2022, v. 16, n. 14, p. 2719, doi. 10.1002/1878-0261.13267
    By:
    • Vessies, Daan C. L.;
    • Schuurbiers, Milou M. F.;
    • van der Noort, Vincent;
    • Schouten, Irene;
    • Linders, Theodora C.;
    • Lanfermeijer, Mirthe;
    • Ramkisoensing, Kalpana L.;
    • Hartemink, Koen J.;
    • Monkhorst, Kim;
    • van den Heuvel, Michel M.;
    • van den Broek, Daan
    Publication type:
    Article
    29